Personalized Care Pathway May Ease Mood Symptoms In Epilepsy
Researchers tested whether a risk-stratified care pathway could be added to routine epilepsy care for adults who also had clinically relevant symptoms of depression or anxiety.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
Researchers tested whether a risk-stratified care pathway could be added to routine epilepsy care for adults who also had clinically relevant symptoms of depression or anxiety.
This paper was a systematic review, which means the authors gathered and summarized earlier studies rather than testing one new group of patients.
This study was a systematic review and meta-analysis.
This study looked at 31 children seen at one tertiary referral center in Kazakhstan for epilepsy or epilepsy-associated neurodevelopmental disorders who were found to have genetic findings considered clinically relevant or potentially relevant.
This study looked at whether epilepsy in children with autism spectrum disorder (ASD) was associated with results from neurologic evaluations, including EEG, brain imaging, genetic testing, and developmental assessments.
This paper combined results from 20 studies of fenfluramine in people with developmental and epileptic encephalopathies (DEEs), a group of severe epilepsy conditions.
This study combined results from randomized controlled trials that tested levetiracetam in children and teens with epilepsy.
This study looked at the genes of 10 adults with genetic generalized epilepsy that had not responded to medicine.
Researchers analyzed genome sequencing data from 14 patients with undiagnosed pediatric movement disorders.